| |
|
|
Preface |
|
|
|
Chapter 1: |
Definitions; And Examples |
|
|
- § 1:1 : Purpose of the Definitions Section1-1
- § 1:2 : Defining Industry Jargon1-2
- § 1:3 : Defining Particular License Terms1-4
- § 1:3.1 : Affiliates1-4
- [A] : Affiliate Restrictions1-6
- § 1:3.2 : Best Efforts1-7
- § 1:3.3 : Combination Products1-10
- § 1:3.4 : Commercially Reasonable Efforts1-10
- § 1:3.5 : Field of Use1-11
- § 1:3.6 : First Commercial Sale1-12
- § 1:3.7 : Improvements1-13
- § 1:3.8 : “Know-How” or “Technology”1-15
- § 1:3.9 : “Licensor” and “Licensee”1-19
- § 1:4 : Case Study: Ambiguities in License Agreements1-19
- § 1:4.1 : The Devil Is in the Details (and the Definitions)1-20
- [A] : Licensee’s Interpretation1-23
- [B] : Patentee’s Interpretation1-23
- [C] : Federal Circuit’s Analysis of Ambiguous Language1-23
- [D] : Construction Against the Drafter1-24
- [E] : Contra Proferentum Only After Construction of the License Agreement1-25
- § 1:5 : Why Patentees Should Consider Licensing Their Patents1-26
- Examples :1 EX-1
|
|
Chapter 2: |
Grant of License; And Examples |
|
|
- § 2:1 : Operative Words2-1
- § 2:2 : Exclusivity2-4
- § 2:3 : Sublicenses2-5
- § 2:3.1 : Reasons to Sublicense2-5
- § 2:3.2 : Sublicense Safeguards2-6
- [A] : Approval of Sublicensee2-6
- [B] : Stepping into the Licensee’s Shoes2-7
- [C] : Revenue Participation2-9
- § 2:4 : Improvements Included in Grant2-9
- § 2:5 : Reservation of Rights: Those Not Specifically Granted Are Retained2-11
- § 2:6 : March-In Rights: Obligations Arising from Federal Funding2-11
- § 2:7 : Most Favored Nation2-13
- § 2:7.1 : All-or-Nothing Option2-15
- § 2:7.2 : More Flexible Approach2-16
- § 2:7.3 : No Retroactive Effect2-16
- § 2:7.4 : Administrative Burden2-17
- § 2:7.5 : Government Sales Exclusion2-17
- § 2:7.6 : Government Regulation Exclusion2-18
- § 2:8 : Reservation of Rights: To Practice the Invention2-19
- § 2:8.1 : Licensor’s Own Use2-19
- § 2:8.2 : Lincensor Grant to Third Parties2-19
- § 2:8.3 : Confidentiality2-21
- § 2:8.4 : Savings Clauses2-23
- § 2:9 : Limiting the Scope of the License Grant for Competitive Reasons2-24
- § 2:10 : Limiting Uses of the Patent2-26
- Examples :2 EX-1
|
|
Chapter 3: |
Term and Termination; And Examples |
|
|
- § 3:1 : Duration3-2
- § 3:1.1 : Life of the Patent3-2
- § 3:1.2 : Number of Years3-2
- § 3:2 : Grounds for Termination3-3
- § 3:2.1 : Acquisition of Licensee by a Competitor3-3
- § 3:2.2 : Failure to Pay Royalties3-4
- § 3:2.3 : Failure to Pay Minimum Royalty3-4
- § 3:2.4 : Lack of Royalty Payments Attributable to Failure to Exploit the License3-5
- § 3:2.5 : Marketing a Competing Product Combined with Failure to Achieve Royalty Goal3-6
- § 3:3 : Curing Breach to Avoid Termination3-7
- § 3:4 : Duties and Rights of Licensee upon Termination3-8
- § 3:4.1 : Duty to Return Confidential Information3-8
- § 3:4.2 : Duty to Cease Further Sublicensing3-8
- § 3:4.3 : Right to Dispose of Inventory3-9
- [A] : Minimum Inventory Value3-9
- [B] : Time Limit in Which to Sell Inventory3-10
- § 3:5 : Treatment of Patent Licenses in Bankruptcy3-11
- § 3:5.1 : Executory Contracts3-11
- § 3:5.2 : Assignment of Nonexclusive Licenses in Bankruptcy3-11
- § 3:5.3 : Assignment of Exclusive Licenses in Bankruptcy3-12
- § 3:5.4 : How a Licensor May Protect Itself in Bankruptcy3-14
- § 3:5.5 : Obligation to Pay Royalties3-14
- § 3:5.6 : Contractual Provisions3-15
- § 3:5.7 : Separating the Right to Receive Royalties from Ownership of the Patents3-17
- Examples :3 EX-1
|
|
Chapter 4: |
Royalties; And Examples |
|
|
- § 4:1 : The Heart of the License4-2
- § 4:2 : Upfront or “Signing” Fees4-2
- § 4:2.1 : Common Versus Preferred Stock4-2
- § 4:2.2 : Stock Warrants4-3
- § 4:3 : Research-Funding Royalties4-6
- § 4:4 : Milestone Payments4-6
- § 4:5 : Minimum Royalty4-8
- § 4:6 : Royalties Based on Sales (Earned Royalties)4-9
- § 4:6.1 : Generally4-9
- § 4:6.2 : Valuation of Sales4-9
- § 4:6.3 : Affiliate or Sublicensee Sales4-11
- § 4:6.4 : Combination Sales4-11
- § 4:6.5 : Government Sales4-14
- § 4:6.6 : No Multiple Royalties4-15
- § 4:6.7 : Deduction for Taxes4-15
- § 4:6.8 : Volume Discounts4-16
- § 4:6.9 : When Royalties Accrue4-17
- § 4:6.10 : Double Royalties4-18
- § 4:7 : Government-Imposed Royalty Ceilings4-19
- § 4:8 : Royalties Paid by Licensees Outside the United States4-20
- § 4:8.1 : Currency Conversion Date4-20
- § 4:8.2 : Repatriation of Profits4-21
- § 4:9 : Enforcing Payment Obligations4-21
- § 4:10 : Royalty Payments If Patent Not Yet Issued4-22
- § 4:11 : Expiration of the Patent4-23
- § 4:12 : Royalties After Patent Expiration4-23
- § 4:12.1 : Absolute Bar (Brulotte v. Thys Co.)4-23
- § 4:12.2 : Absolute Bar Criticized (Scheiber v. Dolby Laboratories)4-24
- § 4:12.3 : Brulotte Not Always Followed4-25
- § 4:12.4 : Practical Effects of Brulotte4-26
- § 4:13 : Determining Royalty Rates4-27
- § 4:14 : Definition of Sublicense Consideration4-28
- Examples :4 EX-1
|
|
Chapter 5: |
Record Keeping and Reports; And Examples |
|
|
- § 5:1 : Importance of Record Retention5-1
- § 5:2 : Duration of Record Retention5-2
- § 5:3 : Certification of Royalty Statements5-3
- § 5:4 : Right to Audit5-3
- § 5:4.1 : Justification5-3
- § 5:4.2 : Causes of Underreporting5-4
- § 5:4.3 : Who Pays5-5
- § 5:4.4 : Minimizing Inconvenience5-6
- § 5:4.5 : Frequency5-7
- § 5:4.6 : Confidentiality5-8
- § 5:4.7 : Information Revealed to Licensor5-9
- § 5:4.8 : Copies of Licensee’s Records5-10
- § 5:4.9 : Copies of the Audit5-12
- § 5:5 : Licensee’s Audited Financial Statements5-12
- § 5:6 : Small-Fry Provisions5-12
- § 5:7 : Information to Be Reported5-13
- Examples :5 EX-1
|
|
Chapter 6: |
Prosecution and Maintenance; And Examples |
|
|
- § 6:1 : Importance of Maintenance and Prosecution of Licensed Patent Rights6-2
- § 6:2 : Control over the Process6-2
- § 6:3 : Improvements6-4
- § 6:4 : No Burden, No Benefit6-4
- § 6:5 : Apportionment of Prosecution Costs6-5
- § 6:6 : PTO Maintenance Fees6-6
- § 6:7 : Incapacitation6-6
- § 6:8 : Importance of Patent Marking6-7
- § 6:8.1 : Marking Not Required for Method or Process Claims6-9
- § 6:8.2 : False Marking6-10
- [A] : Pequignot v. Solo Cup Co.6-10
- [A][1] : Article Covered by an Expired Patent Is “Unpatented”6-12
- [A][2] : Intent to Deceive Required (“For the Purpose of Deceiving the Public”)6-13
- [A][2][a] : Rebuttable Presumption of Intent to Deceive6-13
- [A][2][b] : Knowledge Is Insufficient to Prove Intent if the Marker Did Not Consciously Desire That the Public Be Deceived6-13
- [A][2][c] : Burden of Proof Is Preponderance of Evidence6-14
- [A][2][d] : Rebutting the Presumption: Expired Patent Markings6-14
- [A][2][e] : Rebutting the Presumption: “May Be Covered” Language6-15
- [A][3] : Conclusion6-16
- [B] : Forest Group, Inc. v. Bon Tool Co.6-16
- [B][1] : Intent to Deceive6-16
- [B][2] : Penalties Must Be Imposed on a Per-Article Basis6-17
- [B][2][a] : Statutory Language6-18
- [B][2][b] : Policy Considerations6-19
- [B][2][c] : The Qui Tam Provision6-19
- [B][2][d] : Comfort Language?6-20
- [B][2][e] : Conclusion6-20
- [C] : Practice Tips6-21
- [D] : Contractual Provisions6-22
- [D][1] : Obligate the Licensee to Properly Mark6-22
- [D][2] : Prohibit Licensee from Removing Marks6-22
- [D][3] : Licensor Responsible for Accuracy6-23
- [D][4] : Licensor Obligation to Inform When to Discontinue Marking6-23
- [D][5] : Licensor Indemnification for Incorrect Information6-23
- Examples :6 EX-1
|
|
Chapter 7: |
Infringement; And Examples |
|
|
- § 7:1 : Key Issues7-1
- § 7:2 : Which Party to Bring Suit7-2
- § 7:3 : Ability to Name the Licensor7-3
- § 7:4 : Who Pays If Licensor Is Named by Licensee7-3
- § 7:5 : Licensor Consent to Settlement Reached by Licensee7-5
- § 7:6 : Indemnifying the Licensor from Sanctions7-5
- § 7:7 : Licensor May Sue If Licensee Does Not7-6
- § 7:8 : Licensor’s Protection in Declaratory Judgment Actions7-7
- § 7:9 : Licensee Not to Encourage Others to Infringe7-7
- Examples :7 EX-1
|
|
Chapter 8: |
Indemnification; And Examples |
|
|
- § 8:1 : Purpose of Indemnification8-2
- § 8:2 : Infringement Indemnity8-2
- § 8:3 : California Law Considerations8-3
- § 8:3.1 : Flexibility8-3
- § 8:3.2 : Section 2778 of the Civil Code8-4
- § 8:3.3 : Parties May Opt Out of Section 27788-5
- § 8:3.4 : Duty to Defend8-5
- [A] : Duty to Defend Is Different from Duty to Pay Defense Costs8-5
- [B] : Duty Is Statutory, but May Be Excluded8-6
- [C] : Damages8-6
- [D] : Duty to Defend Arises Immediately Upon Tender8-7
- [E] : Circumstances in Which the Duty Would Terminate8-7
- § 8:3.5 : Indemnity for Intellectual Property Infringement Can Be Parsed8-8
- § 8:4 : What Is Protected8-8
- § 8:5 : “Maximum Extent Permitted by Law”8-9
- § 8:6 : Indemnification of Sublicensees8-9
- § 8:7 : Immediate Payment8-9
- § 8:8 : Threshold Amount8-10
- § 8:9 : Indemnification to Survive License Termination8-11
- § 8:10 : No Personal Liability; No Piercing the Corporate Veil8-11
- § 8:11 : Failure to Defend8-11
- § 8:12 : Indemnitee Responsible for Aggravated Damages8-12
- § 8:13 : Mitigation8-12
- § 8:14 : Keeping the Indemnitee Honest8-13
- § 8:15 : Indemnification on an After-Tax Basis8-13
- § 8:16 : Infringement Excluded from Indemnification8-14
- § 8:17 : Ways in Which Licensors Reduce Their Indemnity Risk8-15
- § 8:17.1 : Indemnification Limited to Patents of Which Licensor Is Aware As of Effective Date8-15
- § 8:17.2 : Indemnification Limited to Capped Amounts8-16
- § 8:17.3 : Indemnification Obligation Satisfied by Corrective Acts8-17
- § 8:17.4 : Indemnification Limited by Licensee’s Acts8-18
- Examples :8 EX-1
|
|
Chapter 9: |
Export Controls; And Examples |
|
|
- § 9:1 : Exporting Technology: Scope of Federal Regulation9-1
- § 9:2 : Delegating Responsibility to the Licensee9-2
- § 9:3 : Acknowledging Possible Prohibition or Delay9-3
- § 9:4 : Caveat for Licensees Regarding Vague Responsibilities9-3
- § 9:5 : Caveat for Licensors Regarding Representations of Compliance9-4
- § 9:6 : No Contravention of the Law9-5
- § 9:7 : Indemnification9-6
- Examples :9 EX-1
|
|
Chapter 10: |
Use of Licensor's Names; And Examples |
|
|
- § 10:1 : Why Use of Licensor’s Names Is Important10-1
- § 10:2 : Allowing Use: Potential Advantages to Licensor10-1
- § 10:3 : Protecting Image, Reputation, and Goodwill10-2
- § 10:4 : Enforcing Proper Behavior10-3
- § 10:5 : Prohibition of Use10-3
- § 10:6 : Exception for Public Filing and Financing Efforts10-4
- § 10:7 : Quality Controls and Product Monitoring10-5
- Examples :10 EX-1
|
|
Chapter 11: |
Representations and Warranties; And Examples |
|
|
- § 11:1 : Introduction11-1
- § 11:2 : Representation of Validity: No Prior Art Withheld During Prosecution11-2
- § 11:3 : Simple Representation of Ownership11-2
- § 11:4 : More Complete Representation of Ownership11-2
- § 11:4.1 : Inventorship11-3
- § 11:4.2 : No Further Rights Required11-5
- § 11:4.3 : Patent Application Status11-5
- § 11:4.4 : No Dilution of Exclusivity11-6
- § 11:4.5 : Clean Title11-6
- § 11:5 : Overbroad Representations11-7
- § 11:6 : Representations Regarding Technical Soundness11-8
- § 11:7 : Representations Regarding Infringement11-9
- Examples :11 EX-1
|
|
Chapter 12: |
Due Diligence; And Examples |
|
|
- § 12:1 : Why Licensors Want to Impose Due Diligence Obligations12-1
- § 12:2 : Discretion in Choice of Initial Markets12-3
- § 12:3 : Minimum Expenditures12-4
- § 12:4 : Specified Efforts Towards Commercialization12-5
- § 12:5 : Specified Obligations Are Several12-6
- § 12:6 : Licensee May Not Engage in Conflicting Activities12-7
- § 12:7 : Licensor’s Technical Assistance to Licensee12-8
- § 12:7.1 : Literature12-9
- § 12:7.2 : Logistics and Expenses12-9
- [A] : Mutual Training Obligations12-9
- [B] : Licensor’s Training Obligations to Licensee12-10
- [C] : Limit to Number of Licensee Employees Trained12-11
- [D] : Frequency of Training Sessions12-11
- [E] : Not Licensee’s Employees12-11
- [F] : Liability and Insurance12-12
- [G] : Cap on Licensor’s Costs12-13
- [H] : Interference with Licensor’s Operations12-13
- § 12:7.3 : Limit to Information Requests12-13
- § 12:8 : Improvements12-15
- § 12:8.1 : Notice of Improvements12-15
- § 12:8.2 : Improvements to Be Included in License12-16
- § 12:8.3 : Abandonment of Patent Rights to Improvement12-17
- § 12:9 : Collaboration12-18
- § 12:10 : Outline of the FDA Approval Process12-18
- Examples :12 EX-1
|
|
Chapter 13: |
Confidentiality; And Examples |
|
|
- § 13:1 : Why the Need13-1
- § 13:2 : Proper Use of Confidential Information13-2
- § 13:3 : No Reverse Engineering13-2
- § 13:4 : Samples13-3
- § 13:5 : Arbitration13-3
- § 13:6 : Terms of the Agreement13-4
- § 13:7 : Defining Confidential Information13-5
- Examples :13 EX-1
|
|
Chapter 14: |
Arbitration; And Examples |
|
|
- § 14:1 : Patent-Related Arbitration14-1
- § 14:2 : Secrecy14-2
- § 14:3 : “Arising Out of” Versus “Relating To”14-3
- § 14:4 : Limiting Discovery14-4
- § 14:5 : Arbitrator Expertise14-5
- § 14:6 : Limitation on Damages Awardable14-6
- § 14:7 : Venue and Choice of Law14-6
- § 14:8 : Further Restrictions on the Arbitrator14-7
- Examples :14 EX-1
|
|
Chapter 15: |
Miscellaneous; And Examples |
|
|
- § 15:1 : Assignment15-2
- § 15:1.1 : Consent of Licensor15-2
- § 15:1.2 : Participation in Any Consideration for the Assignment15-3
- § 15:1.3 : Assignee Assumes Obligations15-4
- § 15:1.4 : Assignment Not a Release of Licensee’s Accrued Obligations15-4
- § 15:1.5 : Licensee Guarantees Assignee Performance15-4
- § 15:1.6 : Transfer of Business15-5
- § 15:1.7 : De Facto Assignments15-5
- § 15:2 : Merger15-6
- § 15:3 : Severability15-6
- § 15:3.1 : Basic Provision15-6
- § 15:3.2 : Reformation by the Parties15-7
- § 15:3.3 : Reformation by the Court15-7
- § 15:3.4 : Waiver of Invalid Provisions15-8
- § 15:3.5 : All-Inclusive Provision15-9
- § 15:4 : Patent Marking15-10
- § 15:5 : Waiver15-10
- § 15:6 : Notice15-11
- § 15:7 : Independent Contractors15-11
- § 15:8 : Counterparts15-12
- § 15:9 : Force Majeure and Hardship15-12
- § 15:10 : Further Assurances15-13
- § 15:11 : Governing Law (Without Venue or Jurisdiction Provisions)15-14
- § 15:12 : Jurisdiction, Venue, and Service15-14
- § 15:13 : United States Manufacture15-15
- § 15:14 : Most Favored Licensee15-15
- § 15:15 : Reservations15-17
- § 15:16 : Reverse Engineering15-18
- § 15:17 : Construction15-20
- § 15:18 : Headings15-20
- § 15:19 : No Finder’s Fee15-20
- § 15:20 : Costs of Agreement15-20
- § 15:21 : No Strict Construction15-21
- § 15:22 : Publicity15-21
- § 15:23 : Consent15-23
- § 15:24 : Taxes15-24
- § 15:25 : No Endorsement15-25
- § 15:26 : No Third Party Beneficiaries15-25
- § 15:27 : Effect of Merger on Third Party Infringement15-25
- § 15:28 : Amendments15-26
- § 15:29 : Agreement Not to Solicit Employees15-26
- § 15:30 : Intellectual Property of Inventor’s Spouse15-26
- § 15:31 : Compliance with Law15-27
- § 15:32 : Governmental Approvals15-27
- § 15:33 : No Fiduciary Duties15-28
- Examples :15 EX-1
|
|
Chapter 16: |
License Negotiations |
|
|
- § 16:1 : Introduction16-1
- § 16:2 : Long-Term Relationship16-1
- § 16:2.1 : Multiple Nonexclusive Licenses16-2
- § 16:3 : Planning16-2
- § 16:3.1 : Know Your Position16-2
- § 16:3.2 : Put Expectations in Writing16-3
- § 16:3.3 : Deal Points16-4
- § 16:4 : Useful Habits for Negotiators16-5
- § 16:4.1 : Listen and Observe16-5
- § 16:4.2 : Ask If You Do Not Understand16-6
- § 16:4.3 : Be Brief and Clear16-7
- § 16:5 : Patterns of Negotiating Behavior16-7
- § 16:5.1 : Good Cop/Bad Cop16-7
- § 16:5.2 : The Backtracking Negotiator16-8
- § 16:5.3 : The Intimidator16-8
- § 16:5.4 : How to Walk Away from a Negotiation16-9
- § 16:5.5 : If the Other Side Walks Away16-11
- [A] : When You Are at Fault16-11
- [B] : When the Other Side Is at Fault16-11
- § 16:5.6 : The Phantom Boss16-12
- § 16:5.7 : Keep Your Eye on the Ball16-12
|
|
Chapter 17: |
Strategies for the New Patent Law Frontier; And Examples |
|
|
- § 17:1 : Strategies Are Needed to Address Changes in the Law17-4
- § 17:2 : Declaratory Judgments: The New Frontier17-5
- § 17:2.1 : MedImmune17-5
- [A] : Facts17-5
- [B] : Holding17-6
- § 17:2.2 : SanDisk: Federal Circuit Construes MedImmune17-7
- [A] : Facts17-7
- [B] : Holding17-11
- [C] : Promise Not to Sue: Actions Speak Louder Than Words17-12
- [D] : What’s a Patentee to Do? The Federal Circuit Offers Advice17-13
- [E] : What Is a “Suitable” Confidentiality Agreement?17-14
- [E][1] : Confidentiality17-14
- [E][2] : Nonuse17-14
- [E][3] : Nonlitigation Provision17-15
- § 17:3 : Tactics and Strategies After MedImmune and SanDisk17-15
- § 17:3.1 : Licensee Tactics17-15
- [A] : Limiting Infringement Damages Under the Guise of a License Agreement17-15
- [B] : Attempting to Renegotiate License Terms17-16
- § 17:3.2 : Second Circuit’s Speakeasy Case: Under Lear, Inc. v. Adkins, No-Challenge Clauses Unenforceable If Entered into Before Litigation17-16
- [A] : Background17-16
- [B] : The Lear Case17-18
- [C] : Four Ways That Patent Disputes Are Resolved17-19
- [D] : Reasoning of MCA Is Persuasive17-22
- [E] : Absence of Discovery Forecloses Opportunity to Assess Patent Validity17-23
- [F] : Distinguishing Federal Circuit’s Baseload Energy, Inc.17-24
- [G] : Lear Leaves Some Discretion: The Balancing Test17-25
- [H] : Comments and Questions About Speakeasy17-25
- [H][1] : No Reference to MedImmune17-25
- [H][2] : Federal Circuit Declined Jurisdiction17-26
- [H][3] : Scope of the Decision?17-26
- [H][4] : Will the Decision Encourage Litigation?17-26
- [H][5] : Liquidated Damages Prohibited?17-26
- [H][6] : Alternate Dispute Resolution?17-27
- § 17:3.3 : Licensor Tactics17-27
- [A] : Severability and Blue Line Provisions17-27
- [B] : Prohibition on Challenges17-27
- [B][1] : Prohibition More Favorable to Licensee17-28
- [C] : Termination Upon Challenge17-29
- [D] : Termination with Cure17-29
- [E] : Termination with Cure by Dismissal of Action17-30
- [F] : Prepaid and Signing Royalties17-30
- [G] : Royalty Payments Continue During Declaratory Judgment Action17-31
- [G][1] : Royalty Payments Not Escrowed17-31
- [G][2] : Must the Licensee Repudiate the License Agreement?17-31
- [H] : Increased Royalties Upon Bringing a Declaratory Judgment Action17-31
- [I] : Increased Royalties Upon Losing Declaratory Judgment Action17-32
- [J] : Signing Royalties Nonrefundable17-32
- [K] : Licensee Pays Patentee’s Attorneys’ Fees17-32
- [K][1] : Attorneys’ Fees If Challenge Is Brought17-33
- [K][2] : Attorneys’ Fees If Challenge Is Unsuccessful17-33
- [L] : Choice of Venue17-33
- [M] : File First, Negotiate Later17-33
- [N] : Licensee Admissions17-34
- [O] : Definition of “Patent Challenge”17-34
- [P] : Controlling Sublicensees17-35
- [Q] : No Termination for Challenge As Defense Outside Scope of License17-35
- [R] : Drop Dead; No Opportunity to Cure17-36
- [S] : No Future Challenges17-37
- [T] : “Show Me Your Cards”17-37
- [U] : Solicitation Letters17-38
- [V] : Advantages of Arbitration17-38
- § 17:3.4 : Conclusion17-39
- § 17:4 : Quanta Computer: Rebirth of Patent Exhaustion?17-39
- § 17:4.1 : Doctrine of Patent Exhaustion (or “First Sale” Doctrine)17-40
- § 17:4.2 : Facts in Quanta Computer17-41
- § 17:4.3 : Reliance on Univis Lens Case17-42
- § 17:4.4 : Patent Exhaustion Applies to Method Claims17-43
- § 17:4.5 : A Product Must Embody a Patent to Trigger Exhaustion17-45
- § 17:4.6 : Patent Exhaustion Can Be Applied Across Patents17-47
- § 17:4.7 : Exhaustion Is Triggered Only by a Sale Authorized by the Patent Holder17-47
- § 17:4.8 : Authorized Sale Exhausts the Patent Rights17-48
- § 17:4.9 : What Quanta Means to Practitioners17-49
- [A] : The Contracts and Conditions in Quanta17-49
- [B] : Restrictions or Conditions Should Be in the License Agreement17-50
- [C] : Are Restrictions and Conditions Still Allowed?17-51
- [D] : What Conditions or Restrictions Are Available?17-52
- [E] : Reasons for Restricted Licenses17-53
- [F] : Restrictions in Practice17-53
- [G] : Separately Licensing Consumers17-54
- [H] : Digital Rights Management17-54
- [I] : License but Do Not Sell (Software Model)17-55
- [J] : Higher Up-Front Royalties17-55
- [K] : Confirmation That Purchaser Is Separately Licensed17-55
- [L] : Termination of License Grant for Breach17-56
- [M] : When Does a Sale Exhaust the Patent?17-56
- [N] : Is It Helpful to State Whether Licensed Products “Substantially Embody” the Licensed Patent?17-57
- [O] : Implied License Distinguished from Patent Exhaustion17-58
- [P] : Effect on Downstream “Infringers”17-58
- [Q] : Contract Remedies17-58
- [Q][1] : Patentee May Enforce Additional Restrictions by Contract17-58
- [Q][2] : Privity of Contract17-59
- [R] : Importance of Selecting Licensees17-60
- [S] : How Can a Purchaser Protect Itself?17-60
- [T] : Restrictions in Biopharma Industry17-60
- [U] : Conclusion: Quanta in a (Very Small) Nutshell17-61
- § 17:5 : Cases Construing Quanta17-61
- § 17:5.1 : TransCore, LP v. Electronic Transaction Consultants Corp.17-61
- [A] : Facts17-61
- [B] : Holding17-63
- [C] : Federal Circuit’s Analysis17-63
- [C][1] : Effect of the Release17-66
- [C][2] : Effect of Legal Estoppel17-66
- [D] : Practice Points17-68
- [E] : Does a Covenant Not to Sue Equal a License?17-69
- § 17:5.2 : LG Electronics, Inc. v. Hitachi, Ltd.17-69
- [A] : Facts17-69
- [B] : Decision17-73
- [B][1] : Substantial Embodiment17-74
- [B][1][a] : Four “Exemplary Inventive Aspects”17-75
- [B][2] : Foreign Sales17-77
- [B][3] : Location of the Relevant Sales17-82
- [C] : Conclusion17-83
- § 17:5.3 : Fujifilm Corp. v. Benun17-83
- § 17:5.4 : Static Control Components v. Lexmark International, Inc.17-84
- [A] : Facts17-84
- [B] : Interpretation of Quanta17-85
- [C] : Consideration of LG Electronics, Inc. v. Hitachi, Ltd.17-88
- [D] : Conclusion: Quanta Has Changed the Game17-89
- § 17:6 : Risks of Declaratory Judgments from Selling Patents17-89
- § 17:6.1 : The Increasing Popularity of Selling Patents17-89
- § 17:6.2 : Absence of Case Law17-90
- § 17:6.3 : Catalyst Corporate Federal Credit Union17-90
- § 17:6.4 : Limelight Networks17-92
- [A] : The Email17-93
- [B] : Online Presentation and Website17-94
- [C] : Statements Concerning Limelight’s Competitors17-96
- [D] : Demand for Payment17-97
- [E] : Promoting Third Parties to Assert Patent Infringement17-97
- Examples :17 EX-1
- Appendix 17A : Complaint, Catalyst Corporate Fed. Credit Union v. IP Navigation Grp., LLC (E.D. Tex. 2012)App. 17A-1
- Appendix 17B : Complaint, Limelight Networks, Inc. v. Allied Security Trust (D. Ariz. 2011)App. 17B-1
- Appendix 17C : Complaint, iLeverage Inc. v. Limelight Networks, Inc. (Cal. Super. Ct. 2011)App. 17C-1
- Appendix 17D : Declaration of Dion Messer in Support of Defendant Limelight Networks, Inc.’s Special Motion to Strike the Complaint (C.C.P. § 425.16), iLeverage Inc. v. Limelight Networks, Inc. (Cal. Super. Ct. 2011)App. 17D-1
- Appendix 17E : Order Granting Defendant Limelight Networks, Inc.’s Special Motion to Strike the Complaint (CCP § 425.16), iLeverage Inc. v. Limelight Networks, Inc. (Cal. Super. Ct. 2011)App. 17E-1
|
|
Chapter 18: |
Table of Examples |
|
|
|
Chapter 19: |
Table of Authorities |
|
|
|
Chapter 20: |
Index to Patent Licensing |
|
|